Cell-free systems for expression of transmembrane protein

Transmembrane proteins (TMPs) are the most important components of cellular membranes They mediate a wide array of biological processes, including signal transduction, ion and metabolite transport, enzymatic catalysis, and cell-cell communication. Due to their central roles in physiological homeostasis and pathophysiological disorders, TMPs are considered prime targets in drug discovery, accounting for more than half of all therapeutic targets. Besides their essential activity in human proteome, their characterization faces several challenges in expression, folding and stability in conventional cell-based systems. Cell-free protein synthesis (CFPS) is a good alternative which offers an open, reproducible, and high-yield platform for TMP production that bypasses many limitations associated with in vivo expression. Fundamental principles, advancements, and applications of CFPS in the context of TMP expression are discussed in this chapter. It highlights various CFPS platforms both from prokaryotic and eukaryotic sources and covers their respective strengths in the production of TMPs. The discussion covers biochemical approaches, such as the incorporation of membrane mimetics, folding chaperones, and non-standard amino acids, as well as technological innovations including hybrid systems, microfluidic reactors, and high-throughput automation. Achieving correct topology and functional reconstitution are thoroughly examined, along with future directions involving modular membrane systems and next-generation synthetic biology tools. By boosting the accessibility and precision of TMP production, CFPS has potential to redefine structural biology, drug discovery, and the development of novel therapeutics. By enabling precise, rapid, and scalable production of TMPs, CFPS has the potential to redefine workflows in structural biology, drug screening, biosensor development, and the production of next-generation biologics.